Indian equities ended lower after four straight gains as profit booking, weak global cues and caution ahead of the US Fed minutes weighed o...

The government's Cochin Shipyard offer for sale drew robust institutional demand, with the non-retail portion subscribed 3.52 times, prompt...

The government plans to sell up to 5.04% of Cochin Shipyard shares. This offer for sale begins July 7 for institutional investors. Retail i...

Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment for schizophreni...

Foreign investors are holding their lowest stake in India's top 10 companies in two decades, coinciding with valuations dipping below long-...

Indian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank an...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

Inspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in India's Bur...

Inspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in Burger King...

M1xchange is an RBI-licensed Treds (Trade Receivables Electronic Discounting System) entity. C2FO runs C2Treds and also has the same licenc...

Shapoorji Pallonji Group is launching a ₹25,500-crore bond issue, leveraging its 18.37% stake in Tata Sons. The bond's repayment hinges on ...

Paisalo Digital shares hit the 20% upper circuit after the company announced that promoter shareholding increased to 46.72% in Q1FY27 from ...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...

Strides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...

Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...